Intraday MarketsStock report · RGC · Regencell Bioscience Holdings Limited · Nov 1, 2026
Intraday Markets
Home › Stocks › RGC

RGC Stock: Price, Earnings History and SEC Filings

Regencell Bioscience Holdings Limited (RGC) last traded at $6.71, down 2.19% on the latest session and up 7.9% over the past month.

$6.71 -2.19%
1 month+7.88%
52-week high$69.00
52-week low$4.51
Volume148,174
ExchangeNasdaqCM

Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.

RGC earnings history

Earnings history is not available right now.

Latest SEC filings for RGC

Insider filing activity

RGC insiders filed 0 Form 4 reports in the last 90 days. A Form 4 is how directors and executives disclose purchases, sales and grants of company stock. See the individual filings on SEC EDGAR. Many Form 4 filings are routine, such as scheduled sales or option exercises, so check each filing before drawing a conclusion.

Source: SEC EDGAR.

RGC news

About Regencell Bioscience Holdings Limited

Regencell Bioscience Holdings Limited (RGC) is a US-listed public company on Nasdaq. The SEC classifies its business as Medicinal Chemicals & Botanical Products. It is incorporated in Cayman Islands.

Open the live terminal

Related stocks

NVDAAAPLMSFTGOOGLAMZNMETATSLAAVGOAll stocks
intradaymarkets.com · Information only, not investment advice · Data from public sources and may be delayed